Literature DB >> 16249930

Prognostic utility of the semi-quantitative procalcitonin test, neutrophil count and C-reactive protein in meningococcal infection in children.

Juan Casado-Flores1, Alfredo Blanco-Quirós, Montserrat Nieto, Julia Asensio, Cristina Fernández.   

Abstract

UNLABELLED: The aim was to determine whether semi-quantitative procalcitonin (PCT-Q) measurements on admission can identify the severity of meningococcal infection in children. A total of 65 children (mean age 2.4 years) with meningococcal disease were included in a prospective study. All patients were treated with antibiotics, rehydration, inotropic drugs and mechanical ventilation if presenting with shock or respiratory failure. On admission, blood was drawn for routine laboratory analyses including absolute neutrophil count (NC), C-reactive protein (CRP) and PCT-Q (immunochromatographic test). A total of 33 patients presented with septic shock on admission of whom 18 developed multiple organ dysfunction syndrome (MODS) and 9 died. Forty-three patients showed a very high PCT-Q level (>or=10 ng/ml), 12 showed values between 2-9.9 ng/ml and the remaining 10 patients showed PCT-Q levels<2 ng/ml. All patients with a PCT-Q level<10 ng/ml survived, whereas all those who developed MODS or died had PCT-Q levels>or=10 ng/ml. Receiver operator curve analysis showed that PCT-Q and NC had a high predictive value for MODS and death. PCT-Q showed a sensitivity of 100%, a negative predictive value of 100% and a negative likelihood ratio of 0.0 for MODS and death.
CONCLUSION: semi-quantitative procalcitonin levels under 10 ng/ml predict good outcome of children with meningococcal infection. It is a highly sensitive method to identify patients with an increased risk of multiple organ dysfunction syndrome or death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249930     DOI: 10.1007/s00431-005-1761-5

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

1.  Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin.

Authors:  M Meisner; F M Brunkhorst; H B Reith; J Schmidt; H G Lestin; K Reinhart
Journal:  Clin Chem Lab Med       Date:  2000-10       Impact factor: 3.694

Review 2.  A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis.

Authors:  Joachim E Fischer; Lucas M Bachmann; Roman Jaeschke
Journal:  Intensive Care Med       Date:  2003-05-07       Impact factor: 17.440

3.  Prognosis of meningococcal septicaemia.

Authors:  J F Sinclair; C H Skeoch; D Hallworth
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321

4.  Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group.

Authors:  R Jaeschke; G Guyatt; D L Sackett
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

5.  Comparison of the performance of two general and three specific scoring systems for meningococcal septic shock in children.

Authors:  A Castellanos-Ortega; M Delgado-Rodríguez
Journal:  Crit Care Med       Date:  2000-08       Impact factor: 7.598

6.  Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children.

Authors:  A Enguix; C Rey; A Concha; A Medina; D Coto; M A Diéguez
Journal:  Intensive Care Med       Date:  2001-01       Impact factor: 17.440

Review 7.  Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock.

Authors:  Joseph A Carcillo; Alan I Fields
Journal:  Crit Care Med       Date:  2002-06       Impact factor: 7.598

8.  Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count.

Authors:  Juan Casado-Flores; Alfredo Blanco-Quirós; Julia Asensio; Eduardo Arranz; Jose A Garrote; Monserrat Nieto
Journal:  Pediatr Crit Care Med       Date:  2003-04       Impact factor: 3.624

9.  Trends in mortality in children hospitalized with meningococcal infections, 1957 to 1987.

Authors:  P L Havens; J S Garland; M M Brook; B A Dewitz; E S Stremski; T J Troshynski
Journal:  Pediatr Infect Dis J       Date:  1989-01       Impact factor: 2.129

10.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

View more
  4 in total

Review 1.  Utility of Procalcitonin as a Biomarker for Sepsis in Children.

Authors:  Kevin J Downes; Julie C Fitzgerald; Scott L Weiss
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

2.  Clinical and Cost-Effectiveness of Procalcitonin Test for Prodromal Meningococcal Disease-A Meta-Analysis.

Authors:  Jennifer M Bell; Michael D Shields; Ashley Agus; Kathryn Dunlop; Thomas Bourke; Frank Kee; Fiona Lynn
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

3.  Relationship of Serum Procalcitonin, C-reactive Protein, and Lactic Acid to Organ Failure and Outcome in Critically Ill Pediatric Population.

Authors:  Imran Siddiqui; Lena Jafri; Qalab Abbas; Ahmed Raheem; Anwar Ul Haque
Journal:  Indian J Crit Care Med       Date:  2018-02

4.  Diagnostic and prognostic value of procalcitonin for early intracranial infection after craniotomy.

Authors:  Y Yu; H J Li
Journal:  Braz J Med Biol Res       Date:  2017-04-20       Impact factor: 2.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.